ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis

Chang, Dongyuan; Xu, Xiao; Yang, Zhikai; Ma, Tiantian; Nie, Jing*; Dong, Jie*北京大学; 南方医科大学; 中国医学科学院
Peritoneal Dialysis International2022-11DOI: 10.1177/08968608211051809
5被引7阅读
引用收藏
分享

摘要

Background: Trimethylamine-N-oxide (TMAO) is a gut bacteria-derived metabolite of l-carnitine and choline. A high concentration of TMAO has been proven to relate to cardiovascular disease (CVD), all-cause mortality and chronic kidney disease progression. We aimed to investigate the relation between the value of serum TMAO and outcomes for peritoneal dialysis (PD) patients. Methods: This is a prospective cohort study with data retrospectively analysed. All incident PD patients were enrolled and followed up. Log-rank test, competing risk survival analysis and COX regression were performed to test the effect of serum TMAO on developing first-episode peritonitis, all-cause and CVD mortality. Results: A wide distribution of serum TMAO concentration was observed in 513 PD patients, with a median level of 72.3 (43.7, 124.7) mu mol/L. Patients with lower TMAO concentration were more likely to be without diabetes and hypertension. Patients with lower TMAO concentration showed better residual kidney function and solute clearance at baseline. Participants in the higher three TMAO quartiles showed an increased risk for first-episode peritonitis (p = 0.039). By competing risk survival analysis, after adjusting for age, sex, diabetes mellitus, CVD, body mass index, albumin, high-sensitive C-reactive protein, potassium, phosphorus, residual kidney function, normalised protein equivalent of total nitrogen appearance and calendar year of catheter implantation, patients in the higher three TMAO quartiles had a statistically or marginally higher risk for first-episode peritonitis compared with patients in the lowest quartile, with hazard ratio (HR) 1.65 (1.05, 2.58), 1.46 (0.92, 2.31) and 1.66 (1.05, 2.61), respectively. In the COX model, patients in the third quartile TMAO group had significantly higher CVD mortality risk compared with the lowest quartile group, as HR 2.27 (1.02, 5.05) after adjusting for various factors. As for all-cause mortality, TMAO did not show any associated effects. Conclusions: Serum TMAO concentration is associated with the risk of first-episode peritonitis and CVD mortality in PD patients. No obvious association between serum TMAO and all-cause mortality was observed.

学科与关键词

关键词
Outcomesperitoneal dialysistrimethylamine-N-oxide
相关
加载中…
  • Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients
    Zhang, Lei; Xie, Feifei; Tang, Haie; Zhang, Xinrong; Hu, Jianxia; Zhong, Xiaohong; Gong, Nirong; Lai, Yunshi; Zhou, Miaomiao; Tian, Jianwei; Zhou, Zhanmei; Xie, Liling; Hu, Zheng; Zhu, Fengxin; Jiang, Jianping*; Nie, Jing*Translational Research, 2022, 240: 50-63.被引 19
  • Trimethylamine-N-Oxide Aggravates Kidney Injury via Activation of p38/MAPK Signaling and Upregulation of HuR
    Lai, Yunshi; Tang, Haie; Zhang, Xinrong; Zhou, Zhanmei; Zhou, Miaomiao; Hu, Zheng; Zhu, Fengxin; Zhang, Lei*; Nie, Jing*Kidney and Blood Pressure Research, 2021.被引 15
  • Trimethylamine-N-oxide (TMAO) and the predicted risk of cardiovascular events after partial nephrectomy
    Zou, Xiangpeng; Xiong, Longbin; Guo, Zhixing; Li, Yuchen; Ning, Kang; Liu, Xiaohua; Xie, Ye; Peng, Yulu; Liu, Yixuan; Cai, Xinyang; Zhao, Boxin; Zhou, Fangjian; Yu, Chunping*; Zheng, Xia*; Campbell, Steven C.; Zhang, Zhiling*Asian Journal of Surgery, 2024, 47(1): 281-288.
查看全部 →

发表信息

论文状态
公开发表
期刊
Peritoneal Dialysis International
发表日期
2022-11
卷期
第 42 卷, 第 6 期
页码
622-630
DOI
10.1177/08968608211051809
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Capital Medical Development Research Fund [2020-2-4079]; Chinese Academy of Medical Sciences Research Unit [2019RU023]

作者

  • C

    Chang, Dongyuan (第一作者)

    chinese acad med sci · peking univ

  • X

    Xu, Xiao

    peking univ · chinese acad med sci

查看全部 6 位作者收起作者
  • Y

    Yang, Zhikai

    chinese acad med sci · peking univ

  • M

    Ma, Tiantian

    peking univ · chinese acad med sci

  • N

    Nie, Jing (通讯)

    southern med univ

  • D

    Dong, Jie (通讯)

    peking univ · chinese acad med sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417